Treatment of cardiac iron overload in thalassemia major

Haematologica. 2003 May;88(5):481-2.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Cardiomyopathies / diagnosis
  • Cardiomyopathies / drug therapy*
  • Cardiomyopathies / etiology
  • Deferiprone
  • Deferoxamine / therapeutic use
  • Drug Therapy, Combination
  • Heart Diseases / epidemiology
  • Heart Diseases / etiology
  • Heart Diseases / mortality
  • Humans
  • Iron / analysis
  • Iron Chelating Agents / therapeutic use*
  • Iron Overload / diagnosis
  • Iron Overload / drug therapy*
  • Iron Overload / etiology
  • Liver / chemistry
  • Myocardium / chemistry
  • Pyridones / therapeutic use
  • beta-Thalassemia / complications*

Substances

  • Iron Chelating Agents
  • Pyridones
  • Deferiprone
  • Iron
  • Deferoxamine